Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
NAR Cancer|August 28, 2023
Co-evolution of <i>AR</i> gene copy number and structural complexity in endocrine therapy resistant prostate cancerAndrej Zivanovic, Jeffrey T Miller, Sarah A Munro, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
The American Journal of Pathology|June 28, 2011
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinasesAaron P Putzke, Aviva P Ventura, Alexander M Bailey, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2019
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate CancerAlexandra N Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, et al.
The Prostate|March 19, 2016
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancerMartine P Roudier, Brian R Winters, Ilsa Coleman, et al.
The Prostate|May 6, 2024
Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasisJuanJuan Yin, Asha Daryanani, Fan Lu, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinomaYi Zhang, Xiaofan Zhao, Huan Wang, et al.
Cancer Discovery|August 15, 2014
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasisJared M Lucas, Cynthia Heinlein, Tom Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate CancerXiaotun Zhang, Ilsa M Coleman, Lisha G Brown, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
NAR Cancer|August 28, 2023
Co-evolution of <i>AR</i> gene copy number and structural complexity in endocrine therapy resistant prostate cancerAndrej Zivanovic, Jeffrey T Miller, Sarah A Munro, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
The American Journal of Pathology|June 28, 2011
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinasesAaron P Putzke, Aviva P Ventura, Alexander M Bailey, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2019
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate CancerAlexandra N Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, et al.
The Prostate|March 19, 2016
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancerMartine P Roudier, Brian R Winters, Ilsa Coleman, et al.
The Prostate|May 6, 2024
Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasisJuanJuan Yin, Asha Daryanani, Fan Lu, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinomaYi Zhang, Xiaofan Zhao, Huan Wang, et al.
Cancer Discovery|August 15, 2014
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasisJared M Lucas, Cynthia Heinlein, Tom Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate CancerXiaotun Zhang, Ilsa M Coleman, Lisha G Brown, et al.
Pageof 23